In this study, we found that CAFs promoted the metastatic potential of NSCLC cells by regulating m6A methylation in NSCLC cells, and demonstrated that METTL3 mediated the CAFs' effect on m6A methylation. The gene discussed is METTL3; the disease is non-small cell lung carcinoma.